Category: Disease Discoveries
-
Mechanism Behind Chronic Fibrosis Discovered
Northwestern Medicine scientists have shown that a molecule called tenascin-C drives the excess scar buildup seen in fibrotic diseases.
-
Studying Blood Test for Early Cancer Detection
Scientists at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University will test Guardant Health’s technology to detect cancer at early stages in high-risk populations.
-
New Gene Shown to Cause Parkinson’s Disease
Mutations in a gene called TMEM230 were definitively linked to confirmed cases of the common movement disorder in a recent Northwestern Medicine study.
-
Investigating Protein Misfolding in Neurodegenerative Diseases
A new study identified a link between gene expression levels and protein aggregation, which can lead to neurodegenerative disorders.
-
Chandel Awarded NCI Outstanding Investigator Award
Navdeep Chandel, PhD, David W. Cugell Professor of Medicine, has received the National Cancer Institute’s Outstanding Investigator Award to explore how mitochondrial metabolism plays a role in cancer.
-
Unlocking the Brain’s Role in Pain
Certain anatomical properties of the brain – not the initial injury – determine most of a patient’s risk of developing chronic pain, according to a new study.
-
Collaborating to Explore Cancer Therapy Resistance
The results of a recent study co-authored by C. David James, PhD, uncovered potential new targets for treating glioblastoma, a fatal brain tumor for which there is currently no cure.
-
Glowing Map of Infection May Shine Light on Female HIV Transmission
Scientists have created a glowing map of the very first cells to be infected with an HIV-like virus, pinpointing the vulnerable points where HIV may enter the female reproductive tract.
-
Nanoparticle Acts Like Trojan Horse to Halt Asthma
A biodegradable nanoparticle can hide an allergen in a friendly shell to convince the immune system not to attack it, according to new Northwestern Medicine research.
-
Stem Cell Method Predicts Patient Response to Cancer Drug
New Northwestern Medicine research has shown that reprogrammed stem cells can be used to identify patients with cancer who are likely to experience a dangerous side effect of a common chemotherapy drug.
